Product Name | EuCorVac-19¢â Inj. Multi-dose (SARS-CoV-2 Spike Protein Vaccine(Recombinant)) |
---|---|
Product Purpose | Prescription Medicine (Export only) |
Administration | Intramuscularly, 2 doses at 4 weeks apart |
Appearance | Injection filled in a colorless and transparent vial with a light green, transparent liquid. |
Efficacy / Effectiveness | Active immunization for the prevention of coronavirus disease 2019(COVID-19) caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) in individuals 18 years of age and older |